WCN26-5088 Irbesartan but not Roflumilast Ameliorates Renal Injury in a Col4a5 R471* Mutant Mouse Model of Alport Syndrome and CKD

Read full text Summarise with VIRAT
Authors: Masami Yamamoto, Masashi Aoyama, Mitsuharu Matsumoto, Takumi Sugawara, Ryosuke Kobayashi, Ryotaro Hari, Yasunori Nio
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Alport syndrome is a hereditary kidney disorder caused by mutations in type IV collagen genes. These mutations lead to structural abnormalities in the glomerular basement membrane, resulting in proteinuria, glomerulosclerosis, and progressive renal dysfunction, ultimately leading to chronic kidney disease (CKD). Although Col4a3 and Col4a5 knockout mice have been reported as models of Alport syndrome, they do not fully reflect the mutation-driven nature of the human disease, limiting clinical relevance.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Complement system in diseases

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105128–105128
Publication date
25 March 2026
Language
EN